Analysis of hepatitis C virus-specific CD8+ T-cells with HLA-A*24 tetramers during phlebotomy and interferon therapy for chronic hepatitis C

Oncology Reports

Volumn 18, Issue 4, 2007, Pages 993-998

  Kaji, Kyosuke ^a   Nakamoto, Yasunari ^a   Kaneko, Shuichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis C; HLA A*24; Interferon therapy; Phlebotomy; Tetramers

Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; HLA A ANTIGEN; HLA A2402 ANTIGEN; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PHLEBOTOMY; VIROLOGY;

ADULT; ANTINEOPLASTIC AGENTS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HLA-A ANTIGENS; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PHLEBOTOMY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 38449088067     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.4.993     Document Type: Article

References (27)

1. Fried MW, Shiffman ML, Reddy KR, et al: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975-982, 2002.
2. Heathcote EJ, Shiffman ML, Cooksley WG, et al: Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 343: 1673-1680, 2000.
3. Davis GL, Esteban-Mur R, Rustgi V, et al: Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 339: 1493-1499, 1998. (Pubitemid 28543497)
4. McHutchison JG, Gordon SC, Schiff ER, et al: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339: 1485-1492, 1998. (Pubitemid 28543496)
5. Tarao K, Rino Y, Ohkawa S, et al: Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 86: 589-595, 1999. (Pubitemid 29379404)
6. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T and Sakamoto N: Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 89: 986-988, 1994. (Pubitemid 24201831)
7. Smith BC, Gorve J, Guzail MA, Day CP, Daly AK, Burt AD and Bassendine MF: Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 27: 1695-1699, 1998. (Pubitemid 28264696)
8. Fontana RJ, Israel J, LeClair P, et al: Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology 31: 730-736, 2000. (Pubitemid 30118643)
9. Kaji K, Nakanuma Y, Harada K, Sakai A, Kaneko S and Kobayashi K: Hemosiderin deposition in portal endothelial cells is a histologic marker predicting poor response to interferon-alpha therapy in chronic hepatitis C. Pathol Int 47: 347-352, 1997. (Pubitemid 27274206)
10. Mandishona E, MacPhail AP, Gordeuk VR, Kedda MA, Paterson AC, Rouault TA and Kew MC: Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans. Hepatology 27: 1563-1566, 1998. (Pubitemid 28264679)
11. Kato J, Kobune M, Nakamura T, et al: Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 61: 8697-8702, 2001. (Pubitemid 34013879)
12. Cerny A and Chisari FV: Immunological aspects of HCV infection. Intervirology 37: 119-125, 1994. (Pubitemid 24289509)
13. Chang KM, Rehermann B and Chisari FV: Immunopathology of hepatitis C. Springer Semin Immunopathol 19: 57-68, 1997. (Pubitemid 27417528)
14. Gruner NH, Gerlach TJ, Jung MC, et al: Association of hepatitis C virus-specific CD8 + T-cells with viral clearance in acute hepatitis C. J Infect Dis 181: 1528-1536, 2000. (Pubitemid 30387741)
15. Rehermann B and Chisari FV: Cell mediated immune response to the hepatitis C virus. Curr Top Microbiol Immunol 242: 299-325, 2000. (Pubitemid 29467531)
16. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 30: 2479-2487, 2000.
17. Nakamoto Y, Kaneko S, Takizawa H, Kikumoto Y, Takano M, Himeda Y and Kobayashi K: Analysis of the CD8-positive T-cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers. J Med Virol 70: 51-61, 2003. (Pubitemid 36368865)
18. Kondo A, Sidney J, Southwood S, et al: Prominent roles of secondary anchor residues in peptide binding to HLA-A*24 human class I molecules. J Immunol 155: 4307-4312, 1995.
19. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T and Shimotohno K: Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 87: 9524-9528, 1990. (Pubitemid 120016475)
20. Choo QL, Richman KH, Han JH, et al: Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88: 2451-2455, 1991. (Pubitemid 21916435)
21. Takamizawa A, Mori C, Fuke I, et al: Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65: 1105-1113, 1991.
22. Yamada G, Tanaka E, Miura T, et al: Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: a multi-institution analysis. J Gastroenterol Hepatol 10: 538-545, 1995.
23. Altman JD, Moss PA, Goulder PJ, et al: Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96, 1996. (Pubitemid 26332731)
24. Ogg GS and McMichael AJ: HLA-peptide tetrameric complexes. Curr Opin Immunol 10: 393-396, 1998. (Pubitemid 28393819)
25. Doherty PC and Christensen JP: Accessing complexity: the dynamics of virus-specific T-cell responses. Annu Rev Immunol 18: 561-592, 2000. (Pubitemid 30365391)
26. Blattman JN, Sourdive DJ, Murali-Krishna K, Ahmed R and Altman JD: Evolution of the T-cell repertoire during primary, memory and recall responses to viral infection. J Immunol 165: 6081-6090, 2000.
27. + T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy. J Clin Immunol 24: 258-271, 2004.